Raymond J. Henley Iii

Array ( [id] => 6362052 [patent_doc_number] => 20020058707 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-05-16 [patent_title] => 'COMPOSITIONS CONTAINING HYPOGLYCEMICALLY ACTIVE STILBENOIDS' [patent_app_type] => new [patent_app_number] => 09/919966 [patent_app_country] => US [patent_app_date] => 2001-08-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 18097 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0058/20020058707.pdf [firstpage_image] =>[orig_patent_app_number] => 09919966 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7636482 [patent_doc_number] => 06380175 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-04-30 [patent_title] => 'Method for enhancement of delivery of THC by the administration of its prodrugs via the nasal route' [patent_app_type] => B1 [patent_app_number] => 09/890556 [patent_app_country] => US [patent_app_date] => 2001-08-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4269 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/380/06380175.pdf [firstpage_image] =>[orig_patent_app_number] => 09890556 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7001004 [patent_doc_number] => 20010053760 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-12-20 [patent_title] => 'Treatment of infarcts' [patent_app_type] => new [patent_app_number] => 09/919116 [patent_app_country] => US [patent_app_date] => 2001-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 5273 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0053/20010053760.pdf [firstpage_image] =>[orig_patent_app_number] => 09919116 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1558495 [patent_doc_number] => 06436401 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-08-20 [patent_title] => 'Methods for alleviating symptoms associated with diabetes and diabetic neuropathy comprising administration of low levels of antibodies' [patent_app_type] => B1 [patent_app_number] => 09/918343 [patent_app_country] => US [patent_app_date] => 2001-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2645 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/436/06436401.pdf [firstpage_image] =>[orig_patent_app_number] => 09918343 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7640186 [patent_doc_number] => 06395729 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-05-28 [patent_title] => 'Use of pyridazino4,5-bindole-1-acetamide derivatives for preparing medicines for treating diseases related to the dysfunction of peripheral benzodiazepin receptors' [patent_app_type] => B1 [patent_app_number] => 09/889983 [patent_app_country] => US [patent_app_date] => 2001-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4626 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/395/06395729.pdf [firstpage_image] =>[orig_patent_app_number] => 09889983 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6624926 [patent_doc_number] => 20020016340 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-02-07 [patent_title] => 'Compositions and methods for treating cataracts' [patent_app_type] => new [patent_app_number] => 09/915020 [patent_app_country] => US [patent_app_date] => 2001-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8324 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0016/20020016340.pdf [firstpage_image] =>[orig_patent_app_number] => 09915020 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6637628 [patent_doc_number] => 20020086894 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-07-04 [patent_title] => 'Combination and method of treatment of cancer utilizing a COX-2 inhibitor and a 3-hydroxy-3-methylglutaryl-coenzyme-a (HMG-CoA) reductase inhibitor' [patent_app_type] => new [patent_app_number] => 09/912703 [patent_app_country] => US [patent_app_date] => 2001-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16595 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0086/20020086894.pdf [firstpage_image] =>[orig_patent_app_number] => 09912703 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6599468 [patent_doc_number] => 20020042436 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-04-11 [patent_title] => 'Use of angiotensin II receptor antagonists for treating acute myocardial infarction' [patent_app_type] => new [patent_app_number] => 09/915048 [patent_app_country] => US [patent_app_date] => 2001-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5018 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0042/20020042436.pdf [firstpage_image] =>[orig_patent_app_number] => 09915048 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6637611 [patent_doc_number] => 20020086893 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-07-04 [patent_title] => 'Medicament' [patent_app_type] => new [patent_app_number] => 09/911906 [patent_app_country] => US [patent_app_date] => 2001-07-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11782 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0086/20020086893.pdf [firstpage_image] =>[orig_patent_app_number] => 09911906 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1570497 [patent_doc_number] => 06498155 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-12-24 [patent_title] => 'Methods of treating thrombocytopenia' [patent_app_type] => B1 [patent_app_number] => 09/856248 [patent_app_country] => US [patent_app_date] => 2001-07-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3758 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/498/06498155.pdf [firstpage_image] =>[orig_patent_app_number] => 09856248 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1446856 [patent_doc_number] => 06369052 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-04-09 [patent_title] => 'Combination of huperzine and nicotinic compounds as a neuroprotective agent' [patent_app_type] => B1 [patent_app_number] => 09/910819 [patent_app_country] => US [patent_app_date] => 2001-07-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 5 [patent_no_of_words] => 10868 [patent_no_of_claims] => 58 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/369/06369052.pdf [firstpage_image] =>[orig_patent_app_number] => 09910819 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 853058 [patent_doc_number] => 07378443 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-05-27 [patent_title] => 'Fatty acid analogues for the treatment of cancer' [patent_app_type] => utility [patent_app_number] => 10/312901 [patent_app_country] => US [patent_app_date] => 2001-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 4335 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/378/07378443.pdf [firstpage_image] =>[orig_patent_app_number] => 10312901 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1500978 [patent_doc_number] => 06486177 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2002-11-26 [patent_title] => 'Methods for treatment of cognitive and menopausal disorders with D-threo methylphenidate' [patent_app_type] => B2 [patent_app_number] => 09/903803 [patent_app_country] => US [patent_app_date] => 2001-07-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5797 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/486/06486177.pdf [firstpage_image] =>[orig_patent_app_number] => 09903803 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1173454 [patent_doc_number] => 06750221 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-06-15 [patent_title] => 'Use of 5-ht5-ligands in the treatment of neurodegenerative and neuropsychiatric disturbances' [patent_app_type] => B1 [patent_app_number] => 09/889157 [patent_app_country] => US [patent_app_date] => 2001-07-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 9347 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 78 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/750/06750221.pdf [firstpage_image] =>[orig_patent_app_number] => 09889157 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1586381 [patent_doc_number] => 06358991 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2002-03-19 [patent_title] => 'Methods of treating neuropeptide Y-related conditions' [patent_app_type] => B2 [patent_app_number] => 09/896362 [patent_app_country] => US [patent_app_date] => 2001-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8687 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/358/06358991.pdf [firstpage_image] =>[orig_patent_app_number] => 09896362 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1417190 [patent_doc_number] => 06512007 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-01-28 [patent_title] => 'Use of galiella lactone' [patent_app_type] => B1 [patent_app_number] => 09/895685 [patent_app_country] => US [patent_app_date] => 2001-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 8 [patent_no_of_words] => 6934 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/512/06512007.pdf [firstpage_image] =>[orig_patent_app_number] => 09895685 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1504162 [patent_doc_number] => 06465454 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2002-10-15 [patent_title] => 'Combinations of statins and estrogenic agents' [patent_app_type] => B2 [patent_app_number] => 09/896353 [patent_app_country] => US [patent_app_date] => 2001-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9309 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/465/06465454.pdf [firstpage_image] =>[orig_patent_app_number] => 09896353 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1021724 [patent_doc_number] => 06887853 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-05-03 [patent_title] => 'Use of geldanamycin and related compounds for treatment of fibrogenic disorders' [patent_app_type] => utility [patent_app_number] => 10/312287 [patent_app_country] => US [patent_app_date] => 2001-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 15 [patent_no_of_words] => 7843 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 92 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/887/06887853.pdf [firstpage_image] =>[orig_patent_app_number] => 10312287 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1018054 [patent_doc_number] => 06890948 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-05-10 [patent_title] => 'Use of indole-3-acetic acid derivatives in medicine' [patent_app_type] => utility [patent_app_number] => 10/311332 [patent_app_country] => US [patent_app_date] => 2001-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 13138 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 75 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/890/06890948.pdf [firstpage_image] =>[orig_patent_app_number] => 10311332 [rel_patent_id] =>[rel_patent_doc_number] =>)